Sysmex Stock

Sysmex EBIT

The EBIT of Sysmex (6869.T) as of Jun 16, 2026 is 90.35 TT JPY.In the previous year, EBIT was 80.06 TT JPY — a change of 12.86% (higher).

EBIT

90.35 TTJPY

YoY

12.86%

Last updated:

In 2026, Sysmex's EBIT was 90.35 TT JPY, a 12.86% increase from the 80.06 TT JPY EBIT recorded in the previous year.

The Sysmex EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (B JPY)
Date
EBIT (B JPY)
Jan 1, 2006
10.72 base
Jan 1, 2007
12.72 base
Jan 1, 2008
15.04 base
Jan 1, 2009
14.79 base
Jan 1, 2010
15.71 base
Jan 1, 2011
18.29 base
Jan 1, 2012
19.21 base
Jan 1, 2013
21.8 base
Jan 1, 2014
32.87 base
Jan 1, 2015
44.41 base
Jan 1, 2016
61.08 base
Jan 1, 2017
51.92 base
Jan 1, 2018
60.01 base
Jan 1, 2019
61.43 base
Jan 1, 2020
54.89 base
YEAREBIT (B JPY)
2028 est -
2027 est 104.43
2026 est 94.44
2025 90.35
2024 80.06
2023 73.99
2022 68.95
2021 49.86
2020 54.89
2019 61.43
2018 60.01
2017 51.92
2016 61.08
2015 44.41
2014 32.87
2013 21.8
2012 19.21
2011 18.29
2010 15.71
2009 14.79
2008 15.04
2007 12.72
2006 10.72
Access this data via the Eulerpool API

Sysmex Revenue

Sysmex Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2006
87.89 B JPY
10.72 B JPY
7.26 B JPY
Jan 1, 2007
101.04 B JPY
12.72 B JPY
9.01 B JPY
Jan 1, 2008
110.72 B JPY
15.04 B JPY
9.13 B JPY
Jan 1, 2009
111.84 B JPY
14.79 B JPY
8.01 B JPY
Jan 1, 2010
116.17 B JPY
15.71 B JPY
9.76 B JPY
Jan 1, 2011
124.69 B JPY
18.29 B JPY
11.41 B JPY
Jan 1, 2012
134.74 B JPY
19.21 B JPY
12.01 B JPY
Jan 1, 2013
145.58 B JPY
21.8 B JPY
14.17 B JPY
Jan 1, 2014
184.54 B JPY
32.87 B JPY
20.57 B JPY
Jan 1, 2015
221.38 B JPY
44.41 B JPY
26.64 B JPY
Jan 1, 2016
252.62 B JPY
61.08 B JPY
39.28 B JPY
Jan 1, 2017
249.9 B JPY
51.92 B JPY
40.64 B JPY
Jan 1, 2018
281.94 B JPY
60.01 B JPY
39.22 B JPY
Jan 1, 2019
293.51 B JPY
61.43 B JPY
41.22 B JPY
Jan 1, 2020
301.98 B JPY
54.89 B JPY
34.88 B JPY

Sysmex Margins

Sysmex stock margins

The Sysmex margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Sysmex. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Sysmex.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2006
58.2 %
12.19 %
8.26 %
Jan 1, 2007
56.95 %
12.58 %
8.92 %
Jan 1, 2008
59 %
13.58 %
8.25 %
Jan 1, 2009
63.18 %
13.23 %
7.16 %
Jan 1, 2010
63.43 %
13.52 %
8.4 %
Jan 1, 2011
62.8 %
14.67 %
9.15 %
Jan 1, 2012
61.67 %
14.25 %
8.91 %
Jan 1, 2013
61.13 %
14.98 %
9.73 %
Jan 1, 2014
62.71 %
17.81 %
11.15 %
Jan 1, 2015
56.92 %
20.06 %
12.03 %
Jan 1, 2016
59.65 %
24.18 %
15.55 %
Jan 1, 2017
56.73 %
20.77 %
16.26 %
Jan 1, 2018
56.38 %
21.29 %
13.91 %
Jan 1, 2019
55.06 %
20.93 %
14.05 %
Jan 1, 2020
52.92 %
18.18 %
11.55 %

Sysmex Stock analysis

What does Sysmex do? Sysmex Corp is a Japanese company that has been a leading provider of diagnostic and analytical laboratory systems and solutions for the healthcare industry since its founding in 1968. The company is headquartered in Kobe, Japan and employs over 9,000 people worldwide. History: Sysmex was founded by a group of young scientists in Japan who wanted to develop an automated blood cell analysis system to improve the high workload of manual blood analysis at the time. The company began developing this system and brought it to market in 1972. Business model: Sysmex focuses on the development, production, and sale of diagnostic systems and solutions for medical laboratories around the world. The company specializes in hematology, hemoglobinopathy, hemostasis, urinalysis, immunology, clinical chemistry, and molecular biology. Divisions: Sysmex Corp is divided into three main business divisions: 1. Diagnostic Systems: This division includes hematology, hemoglobinopathy, hemostasis, urinalysis, immunology, clinical chemistry, and molecular biology systems. Sysmex is one of the world's leading providers of hematology analysis devices and also offers molecular biology systems for the diagnosis and monitoring of infectious diseases and cancer. 2. Information Solutions: This division offers software and IT solutions that support laboratory management and the integration of laboratory data to optimize analysis processes. The company also offers solutions for automating laboratory processes and managing laboratory inventory. 3. Life Science: This division focuses on the development of products for the life sciences, particularly cell analysis and imaging, as well as production, processing, and storage of cell cultures. Sysmex is also involved in the production of devices for harvesting mesenchymal stem cells from adipose tissue. Products: Sysmex offers a variety of products, including: - Hematology analysis devices for determining blood cell parameters such as RBC, WBC, HGB, HCT, and platelets. - Hemostasis systems for analyzing blood coagulation. - Molecular biology systems for the diagnosis and monitoring of infectious diseases and cancer. - Urinalysis systems for analyzing urine samples for chemical and microscopic parameters. - Immunology analysis devices for determining specific proteins and antibodies in the blood. - Clinical chemistry analysis devices for analyzing chemical parameters in blood samples. - Software and IT solutions for optimizing laboratory processes and management. - Cell analysis and imaging systems for investigating cell morphology and functions. - Devices for harvesting mesenchymal stem cells from adipose tissue. In summary, Sysmex Corp is a global leader in diagnostic and analytical laboratory systems and solutions for the healthcare industry. In its nearly 50-year history, the company has developed and produced a wide range of products that enable laboratories to perform fast and accurate disease diagnosis. The company has also expanded its business into other areas such as information solutions and the life sciences. Sysmex is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Sysmex's EBIT

Sysmex's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Sysmex's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Sysmex's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Sysmex’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Sysmex stock

EBIT of Sysmex amounted to 80.06 TT JPY 90.35 TT

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Sysmex

All Key Metrics — Sysmex